UB Paderborn / Katalog / Suche / in CDI

1 – 25 von 90

Sortiert nach

Role of P-glycoprotein in Statin Drug Interactions

Pharmacotherapy, 2006-11, Vol.26 (11), p.1601-1607

2006

Link zum Volltext

Verfügbarkeit prüfen

Intraosseous drug administration in children and adults during cardiopulmonary resuscitation

The Annals of pharmacotherapy, 2007-10, Vol.41 (10), p.1679

2007

Link zum Volltext

Verfügbarkeit prüfen

Select Drug-Drug Interactions With Direct Oral Anticoagulants: JACC Review Topic of the Week

Journal of the American College of Cardiology, 2020-03, Vol.75 (11), p.1341

2020

Link zum Volltext

Verfügbarkeit prüfen

2017 ACC Expert Consensus Decision Pathway on Management of Bleeding in Patients on Oral Anticoagulants: A Report of the American College of Cardiology Task Force on Expert Consensus Decision Pathways

Journal of the American College of Cardiology, 2017-12, Vol.70 (24), p.3042-3067

2017

Link zum Volltext

Verfügbarkeit prüfen

2020 ACC Expert Consensus Decision Pathway on Management of Bleeding in Patients on Oral Anticoagulants: A Report of the American College of Cardiology Solution Set Oversight Committee

Journal of the American College of Cardiology, 2020-08, Vol.76 (5), p.594

2020

Link zum Volltext

Verfügbarkeit prüfen

2018 ACC Expert Consensus Decision Pathway on Tobacco Cessation Treatment: A Report of the American College of Cardiology Task Force on Clinical Expert Consensus Documents

Journal of the American College of Cardiology, 2018-12, Vol.72 (25), p.3332-3365

2018

Link zum Volltext

Verfügbarkeit prüfen

2017 ACC Expert Consensus Decision Pathway on Management of Bleeding in Patients on Oral Anticoagulants

Journal of the American College of Cardiology, 2017-12, Vol.70 (24), p.3042-3067

2017

Link zum Volltext

Verfügbarkeit prüfen

Statin‐associated muscle symptoms—A review: Individualizing the approach to optimize care

Pharmacotherapy, 2022-05, Vol.42 (5), p.428-438

2022

Link zum Volltext

Verfügbarkeit prüfen

Reduced Anticoagulant Effect of Dabigatran in a Patient Receiving Concomitant Phenytoin

Pharmacotherapy, 2016-02, Vol.36 (2), p.e5-e7

2016

Link zum Volltext

Verfügbarkeit prüfen

2023 Atrial Fibrillation Guideline-at-a-Glance

Journal of the American College of Cardiology, 2024-01, Vol.83 (1), p.280

2024

Link zum Volltext

Verfügbarkeit prüfen

Evolocumab: Considerations for the Management of Hyperlipidemia

Current atherosclerosis reports, 2018-04, Vol.20 (4), p.17-17, Article 17

2018

Link zum Volltext

Verfügbarkeit prüfen

UPPING THE ANTE ON HEPARIN DOSING: IS IT TIME FOR A CHANGE IN THE MANAGEMENT OF CARDIOVASCULAR PATIENTS IN THE OBESITY ERA?

Journal of the American College of Cardiology, 2016-04, Vol.67 (13), p.533-533

2016

Link zum Volltext

Verfügbarkeit prüfen

Discharge Counseling for Patients with Heart Failure or Myocardial Infarction: A Best Practices Model Developed by Members of the American College of Clinical Pharmacy's Cardiology Practice and Research Network Based on the Hospital to Home (H2H) Initiative

Pharmacotherapy, 2013-05, Vol.33 (5), p.558-580

2013

Link zum Volltext

Verfügbarkeit prüfen

Gemfibrozil in Combination with Statins—Is It Really Contraindicated?

Current atherosclerosis reports, 2016-04, Vol.18 (4), p.18, Article 18

2016

Link zum Volltext

Verfügbarkeit prüfen

Postoperative Antibiotic Prophylaxis Following Cardiac Implantable Electronic Device Placement

The Journal of innovations in cardiac rhythm management (Print), 2019-08, Vol.10 (8), p.3777-3784

2019

Link zum Volltext

Verfügbarkeit prüfen

Higher Maximum Doses and Infusion Rates Compared with Standard Unfractionated Heparin Therapy Are Associated with Adequate Anticoagulation without Increased Bleeding in Both Obese and Nonobese Patients with Cardiovascular Indications

Pharmacotherapy, 2017-04, Vol.37 (4), p.393-400

2017

Link zum Volltext

Verfügbarkeit prüfen

Argatroban for prevention and treatment of thromboembolism in heparin-induced thrombocytopenia

The Annals of pharmacotherapy, 2001-04, Vol.35 (4), p.440

2001

Link zum Volltext

Verfügbarkeit prüfen

High-Impact Articles Related to the Management of Heart Failure: 2008 Update

Pharmacotherapy, 2009-01, Vol.29 (1), p.82-120

2009

Link zum Volltext

Verfügbarkeit prüfen

EVALUATION OF DIRECT ORAL ANTICOAGULANTS (DOACS) IN PATIENTS WEIGHING GREATER THAN OR EQUAL TO ONE HUNDRED TWENTY KILOGRAMS

Journal of the American College of Cardiology, 2020-03, Vol.75 (11), p.2234-2234

2020

Link zum Volltext

Verfügbarkeit prüfen

2018 ACC Expert Consensus Decision Pathway on Novel Therapies for Cardiovascular Risk Reduction in Patients With Type 2 Diabetes and Atherosclerotic Cardiovascular Disease

Journal of the American College of Cardiology, 2018-12, Vol.72 (24), p.3200-3223

2018

Link zum Volltext

Verfügbarkeit prüfen

2017 ACC Expert Consensus Decision Pathway for Transcatheter Aortic Valve Replacement in the Management of Adults With Aortic Stenosis: A Report of the American College of Cardiology Task Force on Clinical Expert Consensus Documents

Journal of the American College of Cardiology, 2017-03, Vol.69 (10), p.1313-1346

2017

Link zum Volltext

Verfügbarkeit prüfen

Pharmacotherapy Considerations in Advanced Cardiac Life Support

Pharmacotherapy, 2006-12, Vol.26 (12), p.1703-1729

2006

Link zum Volltext

Verfügbarkeit prüfen

2017 ACC Expert Consensus Decision Pathway for Optimization of Heart Failure Treatment: Answers to 10 Pivotal Issues About Heart Failure With Reduced Ejection Fraction: A Report of the American College of Cardiology Task Force on Expert Consensus Decision Pathways

Journal of the American College of Cardiology, 2018-01, Vol.71 (2), p.201-230

2018

Link zum Volltext

Verfügbarkeit prüfen

Select Drug-Drug Interactions With Direct Oral Anticoagulants

Journal of the American College of Cardiology, 2020-03, Vol.75 (11), p.1341-1350

2020

Link zum Volltext

Verfügbarkeit prüfen

Newer pharmacotherapy in patients undergoing percutaneous coronary interventions: A guide for pharmacists and other health care professionals : Expert opinion from the american heart association's diagnostic and interventional catheterization committee and council on clinical cardiology, and the American College of Clinical Pharmacy's Cardiology Practice Research Network

Pharmacotherapy, 2006-11, Vol.26 (11), p.1537-1556

2006

Link zum Volltext

Verfügbarkeit prüfen

1 – 25 von 90

Suche als RSS-Feed

Aktive Filter

KollektionWK Lippincott Williams & Wilkins–Connect here FIRST to enable access

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(82)
Mit Volltextzugriff
(78)

Publikationsform

1 weiteren anzeigen...

Weniger anzeigen...

Sprache

Englisch
(89)
Japanisch
(9)

Erscheinungsjahr

n.n

Thema

15 weitere anzeigen...

Weniger anzeigen...

Zeitschrift / Serie

5 weitere anzeigen...

Weniger anzeigen...

Menü

Weitere Dienste

Einstellungen

Role of P-glycoprotein in Statin Drug Interactions

Intraosseous drug administration in children and adults during cardiopulmonary resuscitation

Select Drug-Drug Interactions With Direct Oral Anticoagulants: JACC Review Topic of the Week

2017 ACC Expert Consensus Decision Pathway on Management of Bleeding in Patients on Oral Anticoagulants: A Report of the American College of Cardiology Task Force on Expert Consensus Decision Pathways

2020 ACC Expert Consensus Decision Pathway on Management of Bleeding in Patients on Oral Anticoagulants: A Report of the American College of Cardiology Solution Set Oversight Committee

2018 ACC Expert Consensus Decision Pathway on Tobacco Cessation Treatment: A Report of the American College of Cardiology Task Force on Clinical Expert Consensus Documents

2017 ACC Expert Consensus Decision Pathway on Management of Bleeding in Patients on Oral Anticoagulants

Statin‐associated muscle symptoms—A review: Individualizing the approach to optimize care

Reduced Anticoagulant Effect of Dabigatran in a Patient Receiving Concomitant Phenytoin

2023 Atrial Fibrillation Guideline-at-a-Glance

Evolocumab: Considerations for the Management of Hyperlipidemia

UPPING THE ANTE ON HEPARIN DOSING: IS IT TIME FOR A CHANGE IN THE MANAGEMENT OF CARDIOVASCULAR PATIENTS IN THE OBESITY ERA?

Discharge Counseling for Patients with Heart Failure or Myocardial Infarction: A Best Practices Model Developed by Members of the American College of Clinical Pharmacy's Cardiology Practice and Research Network Based on the Hospital to Home (H2H) Initiative

Gemfibrozil in Combination with Statins—Is It Really Contraindicated?

Postoperative Antibiotic Prophylaxis Following Cardiac Implantable Electronic Device Placement

Higher Maximum Doses and Infusion Rates Compared with Standard Unfractionated Heparin Therapy Are Associated with Adequate Anticoagulation without Increased Bleeding in Both Obese and Nonobese Patients with Cardiovascular Indications

Argatroban for prevention and treatment of thromboembolism in heparin-induced thrombocytopenia

High-Impact Articles Related to the Management of Heart Failure: 2008 Update

EVALUATION OF DIRECT ORAL ANTICOAGULANTS (DOACS) IN PATIENTS WEIGHING GREATER THAN OR EQUAL TO ONE HUNDRED TWENTY KILOGRAMS

2018 ACC Expert Consensus Decision Pathway on Novel Therapies for Cardiovascular Risk Reduction in Patients With Type 2 Diabetes and Atherosclerotic Cardiovascular Disease

2017 ACC Expert Consensus Decision Pathway for Transcatheter Aortic Valve Replacement in the Management of Adults With Aortic Stenosis: A Report of the American College of Cardiology Task Force on Clinical Expert Consensus Documents

Pharmacotherapy Considerations in Advanced Cardiac Life Support

2017 ACC Expert Consensus Decision Pathway for Optimization of Heart Failure Treatment: Answers to 10 Pivotal Issues About Heart Failure With Reduced Ejection Fraction: A Report of the American College of Cardiology Task Force on Expert Consensus Decision Pathways

Select Drug-Drug Interactions With Direct Oral Anticoagulants

Aktive Filter

Suchergebnisse filtern